You can buy or sell Teladoc Health and other stocks, options, ETFs, and crypto commission-free!
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. Read More The company was founded on June 13, 2002 by George Byron Brooks and is headquartered in Purchase, NY.
Purchase, New York
52 Week High
52 Week Low
Teladoc down 5% on critical Forbes article
Teladoc Health (TDOC -5.3% ) is down on more than 60% higher volume on the heels of an article from Forbes Contributor David Trainer who questions the company's use of non-GAAP EBITDA as its main metric of business health and its significant role in management bonuses.
Danger Zone: Incentivizing Executives with Adjusted EBITDA
Getty In recent weeks, I’ve shown how investors who use traditional valuation metrics like price-to-book and price-to-earnings are led to buy low-quality, overvalued stocks. These aren’t the only problematic metrics though. EBITDA, and its more troublesome derivative, adjusted EBITDA, can be even more damaging to an investor’s search for quality stocks. Both of these companies highlight their adjusted EBITDA growth to investors and tie executive compensation to the metric. However, their economic earnings...
Simply Wall St13h
Is Teladoc Health, Inc.’s (NYSE:TDOC) Balance Sheet A Threat To Its Future?
Investors are always looking for growth in small-cap stocks like Teladoc Health, Inc. (NYSE:TDOC), with a market cap of US$4.2b. However, an important fact which most ignore is: how financially healthy is the business? Given that TDOC is not presently profitable, it’s essential to assess the current state of its operations and pathway to profitability. Let’s work through some financial health checks you may wish to consider if you’re interested in this stock. Nevertheless, this is not a comprehensive overvi...
Expected Apr 30, After Hours